Latest From Biotech Now

BIO BizLink Approaches Milestone as Convention Approaches

BIO_BizLink_logo

In less than a year’s time, BIO BizLink, BIO’s peer-rated CRO/CMO database and project management tool, has attracted nearly 1,000 companies looking to connect in the pre-clinical and clinical contract research space! In a recent survey of biotech companies, all of those that responded indicated that they were maintaining or increasing their contract service budget over the coming year. As the industry’s largest event, the 2015 BIO International Convention in Philadelphia is perfect for meeting Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , ,

TSC Global Awareness Day

TSC

On May 15, the Tuberous Sclerosis Alliance (TS Alliance) will join tuberous sclerosis complex (TSC) organizations around the world to observe the fourth annual TSC Global Awareness Day.  On this day, thousands of individuals and families affected by TSC will join together to increase public awareness of the rare disease and share their stories of hope for the future. This year’s TSC Global Awareness Day will feature a social media campaign called #IAMTSC, which will Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Innovation Zone Company Snapshot: Nanofiber Separations

BIO Innovation Zone

Next month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Science foundation (NSF) and the National Institutes of Health (NIH) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Jim Greenwood in New York Times: Specialty Tiers Limit Patient Access

Jim Greenwood

Today, the New York Times published a letter from Jim Greenwood, BIO’s President and CEO. Greenwood’s letter discusses the problems that expanded use of specialty tier cost-sharing by the insurance industry are posing for patients, limiting their access to lifesaving therapies and cures. Breakthrough treatments cost billions of dollars, and investors will only take on such risks if they can expect a reasonable return on their investment. The full text of the letter is below: To Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

European Union Lags Well Behind the U.S. in Innovation

admin-ajax

There are many different explanations for the euro crisis: poor fiscal management, loose banking regulation, etc…But one major contributor to Europe’s problems that continues to hold back economies today is a lack of innovation, reported Simon Nixon of The Wall Street Journal. The European Commission’s own “Innovation Scorecard” shows that on almost every measure of innovation, the European Union lags well behind the U.S. and on some measures now lags parts of Asia, while differences between EU Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,